Will Harvard's gene therapy for Diamond-Blackfan Anemia receive FDA approval by end of 2025? | Binary | | | 1 month ago | |
Will Livdelzi receive full FDA approval by August 14, 2025? | Binary | | | 4 months ago | |
Will Livdelzi achieve $500M in sales by August 14, 2025? | Binary | | | 4 months ago | |
Will Gilead's stock price increase by 10% or more by September 14, 2024? | Binary | | | 4 months ago | |
What will Gilead's market valuation be by August 14, 2025? | Categorical | | | 4 months ago | |
Will Intellia's CRISPR treatment for ATTR enter Phase 2 trials by end of November 2025? | Binary | | | 1 month ago | |
What will be the outcome of Gilead's Livdelzi Phase 3 study for PBC by end of 2024? | Categorical | | | 1 month ago | |
What will be the dominant therapeutic approach for Diamond-Blackfan Anemia by 2026? | Categorical | | | 1 month ago | |
Will Gilead's Livdelzi launch commercially in the US by mid-2025? | Binary | | | 1 month ago | |
What will be the primary outcome of Intellia's CRISPR treatment Phase 1 study for ATTR by end of 2024? | Categorical | | | 1 month ago | |
What market share will Livdelzi capture in the PBC treatment market by August 14, 2025? | Categorical | | | 4 months ago | |
How many new PBC patients will start treatment with Livdelzi by August 14, 2025? | Categorical | | | 4 months ago | |
